Pipetting Samples

A d o p T r a c e l l

Speeding CAR Evolution Under the Radar


In the Press

Making Headlines

Image by Jaron Nix

AdopTracell Granted Technology Validation Start-up Funding (TVSF Phase II)

February 1, 2022

The Ohio Department of Development has awarded AdopTracell with Technology Validation Start-up Funds (TVSF Phase II)  for the company to fully develop its patent protected CAR-Treg immune-therapy for Type 1 Diabetes.  These grants (Phase I, proof-of-concept; Phase II, validation) are awarded to young companies that have licensed innovative technologies from research institutions.

AdopTracell Wins iCorps Award

March 15, 2021

Team AdopTracell wins first grant for CAR Treg commercialization path. 
The FDA Investigational New Drug filing process officially begins.

Image by Scott Graham
Embryonic Stem Cells

Reversal of Autoimmunity with Engineered Adoptive Cell Transfer

May 14, 2020

Our technology becomes public. The news of the discovery of immunosuppresive, antigen-specific CAR Treg cells for prevention and/or treatment of autoimmune and alloimmune disorders is now patented!

February 12, 2019

University of Toledo (formerly Medical College of Ohio) researchers have generated a mouse that mimics the human development and progression of type 1 diabetes, a breakthrough that will open the door to new therapies.